| Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2019 | 562 |
| Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report | Diabetes Care | 2019 | 356 |
| Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia | European Journal of Vascular and Endovascular Surgery | 2019 | 329 |
| Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps | Hepatology | 2019 | 238 |
| Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial | Lancet Oncology, The | 2019 | 215 |
| The Role of Angiogenesis in Hepatocellular Carcinoma | Clinical Cancer Research | 2019 | 166 |
| Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials | JAMA Cardiology | 2019 | 130 |
| Evidence Relating Health Care Provider Burnout and Quality of Care: A Systematic Review and Meta-analysis | Annals of Internal Medicine | 2019 | 125 |
| Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study | Journal of Clinical Oncology | 2019 | 104 |
| Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA | Circulation | 2019 | 103 |
| Which criteria are used to clear patients to return to sport after primary ACL reconstruction? A scoping review | British Journal of Sports Medicine | 2019 | 96 |
| A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia | Brain | 2019 | 82 |
| 3196 Assessing the Relationship between Resilience and Pain Catastrophizing in Patient Reported Outcomes following Total Knee Replacement | Journal of Clinical and Translational Science | 2019 | 78 |
| SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA | Journal of the Endocrine Society | 2019 | 78 |
| THE DUKE INTERAGENCY CARE TEAM: A BRIDGE TO GERIATRIC COMMUNITY RESOURCES | Innovation in Aging | 2019 | 78 |
| 84. Evaluation of the NHSN Standardized Infection Ratio (SIR) Risk Adjustment for HO-CDI in Oncology and ICU Patients in General Acute Care Hospitals | Open Forum Infectious Diseases | 2019 | 78 |
| Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma | Journal of Clinical Oncology | 2019 | 58 |
| Work-life balance behaviours cluster in work settings and relate to burnout and safety culture: a cross-sectional survey analysis | BMJ Quality and Safety | 2019 | 57 |
| B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres | EBioMedicine | 2019 | 45 |
| Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial | Clinical Cardiology | 2019 | 43 |
| Computer vision analysis captures atypical attention in toddlers with autism | Autism | 2019 | 43 |
| Forty-five good things: a prospective pilot study of the Three Good Things well-being intervention in the USA for healthcare worker emotional exhaustion, depression, work-life balance and happiness | BMJ Open | 2019 | 42 |
| Machine learning derived segmentation of phase velocity encoded cardiovascular magnetic resonance for fully automated aortic flow quantification | Journal of Cardiovascular Magnetic Resonance | 2019 | 42 |
| Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma | | 2019 | 41 |
| Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice | Clinical Cancer Research | 2019 | 37 |
